UNSPSC 51362002: Estazolam

This classification denotes a benzodiazepine with the molecular formula C16H11ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36S3EQV54C, chemically known as 8-chloro-6-phenyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepine (iupac) but generally known as estazolam, which bears US NIH Compound Identifier 3261. European Medicines Agency schedules Estazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07241MIG.

UNSPSC 51362002 Estazolam is a Commodity code that captures prescription sedative-hypnotic pharmaceutical products, but recent state and local opportunities tagged under this code actually span a much broader range of pharmaceutical procurement — from naloxone and drug deactivation systems to generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements. State and local health departments, community health agencies, and cooperative purchasing alliances (primarily serving state and local governments) are the primary issuing bodies. The scope reflects how jurisdictions source both specialty pharmaceuticals tied to public health initiatives and broad-based generic drug inventories through established wholesaler networks rather than direct manufacturer relationships, with an emphasis on compliance with federal manufacturing standards, supply-chain security regulations, and competitive pricing models.

Recent activity spans Florida, Minnesota, Oregon, and Texas. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, requiring vendors to handle shipping and meet E-Verify and drug-free workplace certification. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with awarded vendors required to maintain relationships with three authorized wholesalers — AmerisourceBergen, Cardinal Health, and Morris & Dickson — and comply with cGMP and Drug Supply Chain Security Act standards. The Texas Health and Human Services Commission posted Request for Information HHS0017013 (due April 3, 2026) to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels, signaling state interest in alternative contracting models for prescription fulfillment.